Genetic variation within the interleukin-1 gene cluster and ischemic stroke

Stroke

Volumn 43, Issue 9, 2012, Pages 2278-2282

  Olsson, Sandra ^a   Holmegaard, Lukas ^a   Jood, Katarina ^a   Sjögren, Marketa ^b   Engström, Gunnar ^b   Lövkvist, Håkan ^c   Blomstrand, Christian ^a   Norrving, Bo ^c   Melander, Olle ^b   Lindgren, Arne ^c   Jern, Christina ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

cytokine; functional outcome; IL1RN; inflammation; single nucleotide polymorphism; stroke

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE REGISTRY; FEMALE; GENE CLUSTER; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1; RECOVERY OF FUNCTION; STROKE; SWEDEN; TREATMENT OUTCOME;

EID: 84865588842     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.647446     Document Type: Article

References (28)

1. McColl BW, Allan SM, Rothwell NJ. Systemic infection, inflammation and acute ischemic stroke. Neuroscience. 2009;158:1049-1061.
2. Touzani O, Boutin H, LeFeuvre R, Parker L, Miller A, Luheshi G, et al. Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptor. J Neurosci. 2002;22:38-43.
3. Olofsson PS, Sheikine Y, Jatta K, Ghaderi M, Samnegård A, Eriksson P, et al. A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta: interleukin-1 receptor antagonist balance in atherosclerosis. Circ J. 2009; 73:1531-1536.
4. Larsson P, Ulfhammer E, Karlsson L, Bokarewa M, Wahlander K, Jern S. Effects of IL-1beta and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells. Thromb Res. 2008;123:342-351.
5. Osnes LT, Westvik AB, Joø GB, Okkenhaug C, Kierulf P. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine. 1996; 8:822-827.
6. Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Thromb Haemost. 2009;101:929-937.
7. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger Jr. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995; 37:800-805.
8. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995;26:1393-1398.
9. Lalouschek W, Schillinger M, Hsieh K, Endler G, Greisenegger S, Mar-culescu R, et al. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events. Clin Chem Lab Med. 2006;44:918-923.
10. Li N, He Z, Xu J, Liu F, Deng S, Zhang H. Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population. Brain Res Bull. 2010;81:38-42.
11. Um JY, Moon KS, Lee KM, Kim HM. Interleukin-1 gene cluster polymorphisms in cerebral infarction. Cytokine. 2003;23:41-46.
12. Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS, et al. Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res Mol Brain Res. 2003;115:50-54.
13. Zee RY, Hennessey H, Michaud SE, Ridker PM. Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. Atherosclerosis. 2008;201:124-129.
14. Worrall BB, Brott TG, Brown RD Jr, Brown WM, Rich SS, Arepalli S, et al. IL1RN VNTR polymorphism in ischemic stroke: analysis in 3 populations. Stroke. 2007;38:1189-1196.
15. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke. 2004;35:212-227.
16. Jood K, Ladenvall C, Rosengren A, Blomstrand C, Jern C. Family history in ischemic stroke before 70 years of age: the Sahlgrenska Academy Study on Ischemic Stroke. Stroke. 2005;36:1383-1387.
17. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
18. Li C, Engström G, Hedblad B, Berglund G, Janzon L. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke. 2005;36:234-238.
19. Hallström B, Jönsson AC, Nerbrand C, Petersen B, Norrving B, Lindgren A. Lund Stroke Register: hospitalization pattern and yield of different screening methods for first-ever stroke. Acta Neurol Scand. 2007;115: 49-54.
20. Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 2007;8:344-351.
21. Manica-Cattani MF, Bittencourt L, Rocha MI, Algarve TD, Bodanese LC, Rech R, et al. Association between interleukin-1 beta polymorphism (+ 3953) and obesity. Mol Cell Endocrinol. 2010;314:84-89.
22. Reiner AP, Wurfel MM, Lange LA, Carlson CS, Nord AS, Carty CL, et al. Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation. Arterioscler Thromb Vasc Biol. 2008;28:1407-1412.
23. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke. 2006;37:2018-2023.
24. Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C Fibrinogen gene variation and ischemic stroke. J Thromb Haemost. 2008;6:897-904.
25. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurol. 2007;7:5.
26. Christensen H, Boysen G, Christensen E, Johannesen HH, Bendtzen K. Plasma cytokines in acute stroke. J Stroke Cerebrovasc Dis. 2002;11: 72-79.
27. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001;32:2575-2579.
28. Luotola K, Pietila A, Alanne M, Lanki T, Loo BM, Jula A, et al. Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes. Metabolism. 2010;59: 1520-1527.